Acro Biomedical (ACBM) Free Cash Flow Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | -141.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -141.34% |
| Sep 30, 2025 | -758.88% |
| Jun 30, 2025 | -1,384.97% |
| Mar 31, 2025 | -66.74% |
| Dec 31, 2024 | 16.63% |
| Sep 30, 2024 | -1,411.59% |
| Jun 30, 2024 | -381.29% |
| Mar 31, 2024 | -142.78% |
| Dec 31, 2023 | -19.35% |
| Sep 30, 2023 | 100.91% |
| Jun 30, 2023 | 100.65% |
| Mar 31, 2023 | -102.12% |
| Dec 31, 2022 | 82.53% |
| Sep 30, 2022 | 17.48% |
| Jun 30, 2022 | -179.90% |
| Mar 31, 2022 | 3,228.07% |
| Sep 30, 2021 | 0.08% |
| Jun 30, 2021 | 702.48% |
| Mar 31, 2021 | 67.79% |
| Sep 30, 2020 | 31.74% |
| Jun 30, 2020 | 47.76% |
| Mar 31, 2020 | 50.29% |
| Dec 31, 2019 | -79.96% |
| Sep 30, 2019 | -2,171.11% |
| Jun 30, 2019 | 73.16% |
| Mar 31, 2019 | -112.78% |
| Dec 31, 2018 | 624.14% |
| Sep 30, 2018 | 99.00% |
| Jun 30, 2018 | -2,818.75% |
| Mar 31, 2018 | 1,488.95% |
| Dec 31, 2017 | -23,322.54% |
| Sep 30, 2017 | -4,231.55% |
| Jun 30, 2017 | -213.41% |
| Mar 31, 2017 | -260.97% |
| Dec 31, 2016 | 98.75% |
| Sep 30, 2016 | -532.94% |